Clinical Trials
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 1–12 of 75 articles
Quick answer
NovaPharmaNews Clinical Trials hub for NMPA covers 75 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Piyush Goyal Invites Global Pharma Firms to Partner With India
Blood pressure and ischemic stroke risk in dementia: nationwide cohort findings
Drug Discovery Technology Market Size Tops USD 80.27 Billion by 2035
Clinical Trials Outsourcing Market Size: 2026-2034 Growth Outlook
Nektar Therapeutics pipeline update: REZPEG clinical programs and regulatory context
Areas with Risk of Dengue: CDC map, criteria, and global reach
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Data at ADA 2026
ASCO26: Revolution's Daraxonrasib Phase III Data Reshapes Pancreatic Cancer Odds
Poly Medicure appoints Indranil Mukherjee as CEO, APAC & India: Strategic implications for pharma BD teams
Cell Therapy Packaging Market Size & Share Report, 2033: Key Trends and Forecasts
Orion Pharma's ODM-212 Shows Favorable Safety in Phase 1/2 TEADES Trial for Advanced Solid Tumours
The Pharma Choke Point: A Strategic Risk for U.S. Pharmaceutical Supply Chains
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.